6962 Tenax |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Jan-78 | Serial Number Prefix | UB | |
| Registered US Implants | 70,600 | Type and/or Fixation | Transvenous, Vent., Tines | |
| Estimated Active US Implants | 3,200 | Polarity | Bipolar | |
| Advisories | None | Steroid | No | |
| Ventricular Placement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| System Longevity Study Results |
|
|||||||||
| Number of Leads Enrolled in Study | 1,483 | |||||||||
| Cumulative Months of Follow-Up | 109,942 | |||||||||
| Number of Leads Active in Study | 2 | |||||||||
| Qualifying Complications | 52 Total | |||||||||
| Conductor Fracture | 5 | |||||||||
| Extra Cardiac Stimulation | 1 | |||||||||
| Failure to Capture | 27 | |||||||||
| Failure to Sense | 10 | |||||||||
| Impedance Out of Range | 3 | |||||||||
| Insulation (not further defined) | 2 | |||||||||
| Lead Dislodgement | 1 | |||||||||
| Oversensing | 3 | |||||||||
